Carbonic Anhydrase Inhibitors - StatPearls - NCBI Bookshelf
2023年4月17日 · This article reviews the indications, action, and contraindications for carbonic anhydrase inhibitors as valuable agents in treating glaucoma, idiopathic intracranial hypertension, and other disorders.
Glaucoma Eye Drops - American Academy of Ophthalmology
2024年10月9日 · Carbonic anhydrase inhibitors for glaucoma. Carbonic anhydrase inhibitors work by reducing the amount of fluid your eye produces. This helps lower eye pressure and, hopefully, saves your vision. Your ophthalmologist may have you take this medicine as an eye drop or by mouth as a pill. Possible side effects of carbonic anhydrase inhibitors include:
Managing Glaucoma with Carbonic Anhydrase Inhibitors
2024年11月4日 · How do carbonic anhydrase inhibitors help in treating glaucoma? By reducing the production of aqueous humor, carbonic anhydrase inhibitors help to lower intraocular pressure, which can help slow down the progression of glaucoma and prevent further damage to the optic nerve.
Glaucoma: Medications - American Academy of Ophthalmology
2015年11月6日 · Carbonic anhydrase inhibitors (CAIs) work by reducing aqueous production; both oral and topical formulations are available and have been widely used in children with glaucoma.
Topical Carbonic Anhydrase Inhibitors - EyeWiki
Primary open-angle glaucoma (POAG) is a multifactorial optic neuropathy associated visual field loss and progressive retinal ganglion cell death. The main risk factor for POAG is elevated intraocular pressure (IOP), but there are many other associated factors.
List of Carbonic anhydrase inhibitors for Glaucoma - Drugs.com
Carbonic anhydrase inhibitors are mainly used for the treatment of glaucoma or other ocular conditions where lowering of the intraocular blood pressure has been deemed beneficial. Acetazolamide is also used for the treatment and prevention of acute mountain sickness (also known as altitude sickness) and in some types of epilepsy .
Carbonic Anhydrase Inhibitors in Ophthalmology: Glaucoma …
2021年10月31日 · Carbonic anhydrase inhibitors (CAIs) are commonly used pharmacologic agents. A myriad of CAI classes and inhibition mechanisms has been identified over the past decade. The classical CAI is acetazolamide, which has been used for the systemic treatment of glaucoma since 1953.
Glaucoma and the Applications of Carbonic Anhydrase Inhibitors …
2013年1月1日 · Inhibition of carbonic anhydrase (CA, EC 4.2.1.1) has pharmacologic applications in the treatment of glaucoma, a disease affecting a large number of people and characterized by an elevated intraocular pressure (IOP).
Topical carbonic anhydrase inhibitors and glaucoma in 2021
Carbonic anhydrase inhibitors (CAIs) have been used for many decades in the treatment of glaucoma. Systemic CAIs were an early treatment option to lower intraocular pressure by reducing aqueous humour production; however, frequent side effects including polyuria and paresthesia contributed to the ev …
Carbonic Anhydrase Inhibitors - PubMed
2023年4月17日 · This article reviews the indications, action, and contraindications for carbonic anhydrase inhibitors as valuable agents in treating glaucoma, idiopathic intracranial hypertension, and other disorders.